Clinical trial No longer in our active list Interventional Ages 18 and up

Improving blood pressure medication adherence for people living with HIV

Official title: Addressing Barriers to Anti-hypertensive Medication Adherence Among Persons Living With HIV Who Have Achieved Viral Suppression

Run by Duke University · NCT05459077 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing ways to help people living with HIV stick to their blood pressure medications better after their viral load is under control.

More Hypertension trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorDuke University
Academic / other
Locations1 site (Durham, North Carolina)
Trial IDNCT05459077 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with a confirmed HIV diagnosis, undetectable viral load, and a diagnosis of hypertension who are receiving care at the Duke HIV clinic.

Probably not a fit

Patients who do not have hypertension or are not receiving care at the Duke HIV clinic may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to address the barriers that people living with HIV (PWH) face in adhering to antihypertensive medications after achieving viral suppression. It is structured into five aims, focusing on identifying patient-level factors, evaluating provider practices, and adapting healthcare delivery interventions to enhance medication adherence. The study will also assess the feasibility and acceptability of these interventions over a 24-week period. By targeting hypertension management in PWH, the study seeks to improve overall cardiovascular health outcomes.

Why it matters

Potential benefit: If successful, this study could lead to better blood pressure control and reduced cardiovascular disease risk for patients living with HIV.

How similar studies have gone: While there has been limited research specifically targeting antihypertensive medication adherence in PWH, studies addressing medication adherence in chronic conditions have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Aims 1A and 1B

* Age ≥18 years
* Confirmed HIV+ diagnosis
* Undetectable HIV viral load: defined as the most recent HIV viral load \<200 copies/mL checked within the past year (assessed via chart abstraction)
* Hypertension diagnosis in medical records
* Taking an antihypertensive medication
* Receiving care at the Duke HIV clinic

Aim 2

* HIV providers including infectious disease physicians, internists or advance practice practitioners who have a patient pool of PLWH under their care in the last 6 months.

Aim 3A

* Stakeholders composed of willing participants recruited from the Duke ID clinic and may include, HIV providers, clinic directors, nurses, pharmacists, social workers, people living with HIV who have hypertension and take antihypertensive medications, and representatives of the community advisory boards, and any other key stakeholders.

Aim 3 B

* Age ≥18 years
* Confirmed HIV+ diagnosis
* Receiving care at the Duke ID clinic
* Achievement of HIV suppression defined as having HIV-1 RNA \<200 copies/ml
* Take antihypertensive medications
* Uncontrolled BP over a 12 months period defined by participants with systolic BP\>130mmHg on ≥ 2 occasions in the past 12 months as indicated in the individual patient's electronic medical records

Exclusion Criteria:

Aims 1A, 1B and 3B

* Severely hearing or speech impaired, or other disability that would limit participation in the intervention components
* In a nursing home and/or receiving in-patient psychiatric care
* Terminal illness with life expectancy \< 4 months
* No reliable access to a telephone
* Pregnant, breast-feeding, or planning a pregnancy during the study period
* Planning to move out of the area in the next 6 months
* Non-English speaking.

Where it's running

  • Duke University
    Durham, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.